Skip to content
Axe Capital logo Axe Capital Trading News

Archive

Older stories stay here even after leaving the live feed, so shared links and past coverage remain accessible.

558 archived stories across 28 pages.

July 2026

20 stories
The Best Buying Opportunity in Months Might Be Hiding in Plain Sight
2026-07-20 18:01 The Motley Fool Mixed Axe Cap view: Selective NFLX META UBER NBIS
Equities Earnings

Following recent market volatility and a rough stretch, the article highlights emerging buying opportunities in the market. The piece discusses Netflix's recent earnings report and stock decline, while also mentioning other tech stocks as potential investment opportunities during this market dip.

Axe note: Sharp falls in big US tech names like Netflix offer a chance for local investors to think about their portfolios.

Why Did SpaceX Stock Drop Again on Monday?
2026-07-20 17:33 The Motley Fool Negative Axe Cap view: Selective SPCX
Equities Earnings IPOs

SpaceX stock fell below its IPO price after scrubbing a Starship test flight due to engine ignition failures. Despite Elon Musk's promise to retry within days with replacement engines, investors continued selling the stock on Monday. The company trades at 84x trailing revenue with no current profits, leaving analysts questioning the valuation until profitability materializes.

Axe note: SpaceX shares slumped after a failed Starship test, raising valuation concerns amid no profits.

Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?
2026-07-20 17:30 The Motley Fool Positive Axe Cap view: Selective BEAM CRSP LLY
Healthcare Equities

Cathie Wood's Ark Invest has significantly increased its position in Beam Therapeutics, a biotech company using base editing technology for genetic treatments. With multiple clinical programs advancing toward FDA approval and sufficient cash runway through mid-2029, Beam could transform into a commercial biotech company. However, the investment remains speculative and dependent on successful clinical trials and regulatory approvals.

Axe note: Beam Therapeutics’ gene-editing promise is exciting but too early for South African investors to jump in.

3 Dividend Stocks I'd Never Sell No Matter What the Market Does
2026-07-20 17:15 The Motley Fool Positive Axe Cap view: Selective VZ KO ENB CVX
Equities Earnings Capital Returns Commodities

The article identifies three dividend stocks recommended as long-term holds regardless of market conditions: Verizon Communications for its essential telecom services and 19-year dividend growth streak; Coca-Cola for its resilient beverage business and 64-year dividend growth record; and Enbridge for its stable pipeline tollbooth model and 31-year consecutive dividend increases. All three companies have predictable, recurring revenue streams that remain stable during economic downturns.

Axe note: Reliable dividend growers like Verizon, Coca-Cola, and Enbridge show what steady income looks like.

Could Nvidia's Newest Partnership Unlock a Huge AI Growth Market?
2026-07-20 17:15 The Motley Fool Positive Axe Cap view: Selective NVDA PLTR
Technology AI Semiconductors Equities

Nvidia is expanding its AI growth strategy beyond hyperscalers through a new partnership with Palantir to help government agencies build secure, sovereign AI systems. This partnership could open a new market segment for institutional investors, potentially sparking further growth for Nvidia beyond its traditional cloud computing focus.

Axe note: Nvidia’s new deal with Palantir targets government AI, but South African investors should watch USD/ZAR and select JSE tech plays for indirect impact.

Should You Buy Palantir Technologies Stock While It's Trading Below $140?
2026-07-20 17:06 The Motley Fool Negative Axe Cap view: Selective PLTR
Equities Earnings Technology AI

Palantir Technologies has delivered impressive financial results with 85% growth and 44% profit margins, driven by AI capabilities. However, despite a 24% decline this year and trading below $140, the stock remains expensive with a P/E multiple around 150 and forward P/E of 90x, making it vulnerable to sharp sell-offs if growth expectations aren't met.

Axe note: Despite strong growth and margins, Palantir’s sky-high valuation makes it a risky bet for South African investors.

1 Space Stock That's Expected to Grow at a Significantly Faster Rate Than SpaceX Over the Next Few Years
2026-07-20 16:36 The Motley Fool Neutral Axe Cap view: Bearish ASTS
Equities Earnings

AST SpaceMobile is expected to grow at a significantly faster rate than SpaceX over the next few years, with analysts projecting a 246% CAGR through 2028 compared to SpaceX's 69% CAGR. However, both stocks trade at rich valuations with AST SpaceMobile at a P/S multiple of 190 versus SpaceX's 80. Both stocks are highly volatile and speculative, with significant downside risk despite promising growth prospects.

Axe note: AST SpaceMobile’s sky-high growth forecasts come with valuations that make South African investors think twice.

5 Semiconductor Stocks Poised to Outperform This Summer
2026-07-20 16:30 The Motley Fool Positive Axe Cap view: Selective NVDA TSM AVGO MU ASML
Equities Earnings Technology AI

The AI infrastructure boom is driving semiconductor demand, with opportunities across the entire supply chain. Rather than betting on a single chip winner, investors should diversify across chip designers (Nvidia, Broadcom), manufacturers (Taiwan Semiconductor), memory (Micron), and equipment makers (ASML). While valuations are high and cyclical risks exist, long-term AI spending trends remain robust.

Axe note: AI-driven semiconductor demand offers global growth but leaves JSE investors watching the rand and resource-linked firms.

Market Indexes Play Favorites: Tech Wins, Industrials Sulk on Monday
2026-07-20 16:21 The Motley Fool Mixed Axe Cap view: Selective GOOG GOOGL GOOGM GOOGN AAPL CAT MU NVDA AVGO SOXX TSLA INTC MPC VLO
Equities Earnings Commodities Geopolitics

Tech stocks rallied on Monday while industrial stocks lagged, with the Nasdaq up 0.57% and the Dow down 0.30%. Alphabet surged 3% after reports of a new AI chip called 'Frozen v2' that runs Google's Gemini models more efficiently. The semiconductor sector broadly rallied on the news. However, Apple fell 2.4% and Caterpillar dropped 1.2%, offsetting gains. Over 300 companies report earnings this week, with investors seeking clarity on AI spending.

Axe note: Alphabet's AI chip news boosts global tech, while industrials lag, posing mixed signals for the JSE.

If a Stock Market Crash Is on the Way, History Says This Is the Smartest Thing Investors Can Do
2026-07-20 16:15 The Motley Fool Positive Axe Cap view: Selective AAPL MSFT NVDA
Technology AI Semiconductors Equities

Despite the S&P 500's 83% gain since the AI revolution began in late 2022, concerns about elevated valuations and heavy concentration in dominant tech stocks have sparked speculation about a potential market correction. However, historical analysis shows markets have always recovered from downturns. The article recommends maintaining a long-term mindset by investing in quality blue-chip companies with durable business models rather than attempting to time the market or engage in reactive trading.

Axe note: Focus on quality and durability rather than trying to time a potential crash.

ServiceNow Could Be a Great Long-Term Buy. Here's the Bull Case.
2026-07-20 16:11 The Motley Fool Positive Axe Cap view: Selective NOW
Technology AI Semiconductors Equities

ServiceNow is positioning itself as an enterprise productivity engine by turning AI from buzzword into practical execution through its workflow platform that connects systems, approvals, and data across large organizations. While the upside case is compelling due to the sticky nature of its automation solutions, valuation risk remains a consideration for investors.

Axe note: ServiceNow’s practical AI workflows could drive strong customer loyalty but stretched valuation calls for caution.

Chevron vs. ExxonMobil: Only One Deserves a Spot in Your Portfolio Today.
2026-07-20 14:28 The Motley Fool Negative Axe Cap view: Selective CVX
Rates Equities M&A Capital Returns

In a comparison of two major oil giants, ExxonMobil emerges as the superior investment choice over Chevron. While both companies offer attractive dividends, ExxonMobil demonstrates stronger fundamentals with a larger market cap ($611B vs $366B), superior stock performance (150% vs 90% over five years), and better cash generation. Chevron faces headwinds including negative free cash flow in Q1 2026, legal issues, geopolitical risks in Venezuela, and ongoing restructuring from its Hess acquisition, whereas ExxonMobil plans $20 billion in share buybacks for 2026.

Axe note: Chevron's challenges reveal why ExxonMobil is the better energy play for JSE-linked portfolios.

I'd Buy More Chipotle Mexican Grill Before the Market Figures Out What It's Missing
2026-07-20 14:23 The Motley Fool Positive Axe Cap view: Selective CMG
Consumer Retail Equities

Chipotle Mexican Grill's stock has declined 36% over the past year due to sluggish sales growth and rising costs, but the author argues this presents a buying opportunity. With the P/E ratio compressed from 45 to 31 and improved valuation metrics, the stock could rebound once economic pressures ease and consumer spending recovers. The slowdown appears cyclical rather than company-specific, with increased restaurant visits suggesting continued customer interest.

Axe note: Chipotle’s share price has fallen sharply, but a recovery in consumer spending could restore its growth story.

Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
2026-07-20 14:17 The Motley Fool Positive Axe Cap view: Selective PJP IXJ LLY JNJ ABBV
Rates Equities Capital Returns Healthcare

The article compares two healthcare ETFs: Invesco Pharmaceuticals ETF (PJP), which focuses on concentrated U.S. pharma exposure with 29 holdings, and iShares Global Healthcare ETF (IXJ), which offers diversified global healthcare with 110 holdings. PJP delivered superior 1-year returns of 44.90% versus IXJ's 18.20%, though IXJ has a lower expense ratio (0.40% vs 0.57%) and higher dividend yield (1.50% vs 0.90%). The article recommends PJP for investors seeking healthcare exposure due to its stronger performance across most timeframes.

Axe note: Invesco’s focused pharma ETF outperforms the broader iShares global healthcare fund, but local investors should weigh concentration risks and rand impact.

Down More Than 60% From Its High, Has Oracle Stock Become a Bargain Buy?
2026-07-20 14:16 The Motley Fool Neutral Axe Cap view: Selective ORCL ORCLPD
Technology AI Semiconductors Equities

Oracle's stock has plummeted over 60% from its highs due to investor concerns about massive AI infrastructure spending, high debt levels, and dependence on OpenAI. Despite capital expenditures doubling to $55.7 billion and long-term liabilities reaching $176.9 billion, the company maintains strong profit margins and trades at a forward P/E below 16—significantly lower than the S&P 500 average of 22. For long-term investors, Oracle could represent a compelling contrarian buying opportunity as bearish sentiment may be overpriced.

Axe note: Oracle’s steep drop and hefty AI spending pose questions, but attractive valuation hints at potential.

I Let AI Design My Path to Financial Independence -- Here's What Shocked Me
2026-07-20 14:15 The Motley Fool Positive Axe Cap view: Selective SCHD
Rates Equities Capital Returns Technology

A financial writer concerned about AI disruption to his career consulted Claude AI to design a path to financial independence. The AI advisor revealed he had already saved enough to reach 'Coast FI' status, where investments will grow into a full retirement nest egg through compounding alone. The strategy focuses on building a bridge to retirement through passive income from dividends and real estate, with a phased plan to gradually reduce work obligations while maintaining financial security.

Axe note: Using AI-designed financial independence plans highlights dividend income as a reliable bridge to retirement.

Why Intel Stock Soared 278% In the First Half of 2026
2026-07-20 14:10 The Motley Fool Positive Axe Cap view: Selective INTC AAPL TSLA SPCX NVDA
Equities Earnings Technology AI

Intel's stock surged 278% in the first half of 2026 following better-than-expected Q1 results, strong data center revenue growth, and new partnerships with Apple, Tesla, and SpaceX. However, shares have fallen 28% since June as investors question the stock's expensive valuation with a P/E ratio of 904 compared to the tech sector average of 34.

Axe note: Intel’s 278% rally in H1 2026 shows operational strength, but its valuation invites caution.

Germany's 2026 Pension Reform Push -- A Blueprint for the U.S.?
2026-07-20 13:30 The Motley Fool Neutral Axe Cap view: Selective VT
Financials Equities

Germany's pensions commission has proposed sweeping reforms to address financial pressures on its retirement system, including raising the retirement age to 67 by 2031, eliminating early retirement options, and introducing individual investment accounts for pension contributions. The U.S. faces similar challenges with Social Security's trust fund expected to deplete by 2032, and Germany's reform proposals could offer potential solutions for stabilizing the American system.

Axe note: Germany’s plan to raise retirement age and shift savings into markets offers a cautionary tale for South African investors.

Meet the Super Semiconductor ETF Obliterating Nvidia, AMD, and Broadcom This Year
2026-07-20 13:20 The Motley Fool Positive Axe Cap view: Selective DRAM NVDA AMD AVGO SKHY MU SNDK
Geopolitics Technology AI Semiconductors

The Roundhill Memory ETF (DRAM) has doubled since its spring 2026 launch, outperforming major AI chip makers by focusing on high-bandwidth memory (HBM), which has become the critical bottleneck in AI supply chains. The ETF holds ~20 memory companies with 75% concentrated in Samsung, SK Hynix, and Micron, benefiting from tight HBM supply and strong pricing power. However, the fund carries significant risks including extreme concentration, high volatility, geopolitical exposure, and the cyclical nature of memory markets.

Axe note: South African investors should watch memory chip supply constraints shaping USD/ZAR and tech sector sentiment.

Should You Buy Amazon Stock, Even Though It Has Badly Underperformed the S&P 500 and Nasdaq-100 Since Jeff Bezos Stepped Down as CEO?
2026-07-20 13:12 The Motley Fool Positive Axe Cap view: Selective AMZN MSFT GOOG GOOGL GOOGM GOOGN
Equities Earnings Technology AI

Amazon has significantly underperformed the S&P 500 and Nasdaq-100 over the past five years since Andy Jassy took over as CEO, posting only 6.8% annualized returns. The company has lost cloud market share to Microsoft and Alphabet despite AWS remaining the largest provider, and e-commerce growth has slowed. However, recent improvements in AWS growth (28% last quarter), a $364 billion contracted backlog, and a promising AI chip business valued at potentially $50 billion suggest Amazon could turn around, with the stock now trading at a reasonable 29x forward earnings valuation.

Axe note: Amazon’s recent underperformance clouds its comeback despite a strong AWS recovery and AI bets.